Genzyme Corp. downgraded to Hold by Citigroup, Inc.;
Genzyme Corp. was downgraded from Buy to Hold by Citigroup Inc. Monday morning.
Citigroup has downgraded Bank Muscat to 'hold' from 'buy', citing the significant rise in the company's stock price over the past 12 weeks and on concerns related to the outlook for asset quality, Reuters reported.